HSBC Holdings’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.94M Buy
+285,389
New +$5.71M ﹤0.01% 1110
2025
Q4
Sell
-39,661
Closed -$455K 3167
2025
Q3
$455K Sell
39,661
-63,674
-62% -$830K ﹤0.01% 2153
2025
Q2
$1.21M Buy
103,335
+3,277
+3% +$29.9K ﹤0.01% 1716
2025
Q1
$877K Sell
100,058
-21,746
-18% -$274K ﹤0.01% 1810
2024
Q4
$1.76M Buy
121,804
+24,562
+25% +$388K ﹤0.01% 1525
2024
Q3
$2.21M Buy
97,242
+5,907
+6% +$122K ﹤0.01% 1394
2024
Q2
$1.8M Buy
+91,335
New +$2.39M ﹤0.01% 1442
2023
Q3
Sell
-22,436
Closed -$1.26M 2858
2023
Q2
$1.26M Buy
+22,436
New +$1.21M ﹤0.01% 1616
2022
Q3
Sell
-7,235
Closed -$331K 3272
2022
Q2
$331K Buy
7,235
+994
+16% +$51.6K ﹤0.01% 2582
2022
Q1
$475K Sell
6,241
-17,961
-74% -$1.57M ﹤0.01% 2451
2021
Q4
$3.62M Buy
24,202
+5,615
+30% +$860K ﹤0.01% 1419
2021
Q3
$2.72M Sell
18,587
-23,270
-56% -$4M ﹤0.01% 1409
2021
Q2
$8.2M Sell
41,857
-10,499
-20% -$1.9M 0.01% 921
2021
Q1
$9.47M Buy
52,356
+45,202
+632% +$7.81M 0.01% 821
2020
Q4
$1.01M Buy
+7,154
New +$1.04M ﹤0.01% 1698

Other funds holding TXG

HSBC Holdings's TXG Position: Q1 2026 in Review

HSBC Holdings opened a new position in 10x Genomics (TXG) in Q1 2026: 285,389 shares worth $5.94M. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in TXG as recently as Q3 2025.

HSBC Holdings first reported a position in TXG in Q4 2020 and has held it in 15 quarters since. The position peaked at $9.47M in Q1 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • HSBC Holdings held 285,389 shares of 10x Genomics worth $5.94M as of Q1 2026.
  • 10x Genomics was a new HSBC Holdings position in Q1 2026.
  • 10x Genomics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1110 holding.
  • HSBC Holdings first reported a position in 10x Genomics in Q4 2020 and has held it in 15 quarters since.
  • HSBC Holdings's 10x Genomics position peaked at $9.47M in Q1 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.